The Melbourne Gastrointestinal Investigation Unit provide a number of treatment & therapy options for Inflammatory Bowel Disease.

These options include:

• Treatment by injection with the immunomodulator, Methotrexate.
• Treatment with the biologics: Humira [Adalimumab], Remicade [Infliximab] & Entyvio [Vedolizumab].

As part of your treatment, we:

• Organise baseline tests.
• Educate you in: the use of the drug & any potential side effects.
• Our nursing staff will teach you: to self-administer the injections & safe disposal of the sharps.

M.G.I.U. participates in a number of research drug trials for both Crohn’s Disease and Ulcerative Colitis. 

Current research trials are listed below.

• Adalimumab (Humira) in patients with Ulcerative Colitis (UC)
• Vedolizumab in patients with Ulcerative Colitis (UC) and Crohn's Disease (CD)
• Etrolizumab in patients with Ulcerative Colitis (UC) and Crohn's Disease (CD)